Concepedia

Dean Najarian

DN

Statistics

Publications

6

Citations

389

H-Index

6

Active since

1999

Affiliations

Janssen Scientific Affairs (United States)(Current)

Janssen (United States)

University of Campania "Luigi Vanvitelli"

Dean Najarian is an author at Janssen Scientific Affairs (United States) specializing in stigmatization, medicine, and psychiatry.

ORCID

Top concepts

Publications per year

1999–2023

6

Publications

6

Olanzapine Increases Weight and Serum Triglyceride Levels

David N. Osser, Dean Najarian, Robert L. Dufresne · The Journal of Clinical Psychiatry · 1999 · 231 citations · Full text

A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia

Dean Najarian, Panna Sanga, Steven Wang et al. · The International Journal of Neuropsychopharmacology · 2021 · 57 citations · Full text

Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs

Vincent J. Giannetti, Charles F. Caley, Khalid M. Kamal et al. · International Journal of Clinical Pharmacy · 2018 · 51 citations

, , +13

Practical considerations for managing breakthrough psychosis and symptomatic worsening in patients with schizophrenia on long-acting injectable antipsychotics

Christoph U. Correll, Jennifer Kern Sliwa, Dean Najarian et al. · CNS Spectrums · 2018 · 23 citations · Full text

Long-Term Efficacy and Safety of Paliperidone 6-Month Formulation: An Open-Label 2-Year Extension of a 1-Year Double-Blind Study in Adult Participants With Schizophrenia

Dean Najarian, Ibrahim Turkoz, R Karl Knight et al. · The International Journal of Neuropsychopharmacology · 2023 · 14 citations · Full text

1–5 of 6